)
)
Apollomics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Apollomics Inc
Access all reports
Apollomics Inc. is a biopharmaceutical company focused on the discovery and development of oncology treatments. The company specializes in targeted therapies and immuno-oncology drugs designed to address various types of cancer. Apollomics conducts clinical research to advance its pipeline of investigational therapies, through innovative approaches such as small molecules and monoclonal antibodies. The company is headquartered in Foster City, California, and its shares are listed on the NASDAQ.
Latest articles
)
Axon: Making Bullets Obsolete
Axon transformed the TASER from a struggling invention into a $50B public safety giant, redefining policing with tech-driven solutions.
21 Feb 2025
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
Ticker symbol
APLM
Country
🇺🇸 United States